its application to the synthesis of sialidase inhibitor 1. Further
application to the synthesis of the bioactive carbohydrates is now
in progress.
The authors thank MARUKIN BIO, INC. (Kyoto, Japan) for
the generous gift of D-ManNAc. This work was performed
through the Noguchi Fluorous Project.
Notes and references
1 Biology of Sialic Acids, ed. A. Rosenberg, Plenum Press, New York,
London, 1995.
2 M. J. Kiefel and M. von Itzstein, Chem. Rev., 2002, 102, 471.
3 C. T. Holzer, M. von Itzstein, B. Jin, M. S. Pegg, W. P. Stewart and
W.-Y. Wu, Glycoconjugate J., 1993, 10, 40.
Scheme 2 Reagents and conditions: (a) (i) Ac2O, pyridine, CH2Cl2, rt,
24 h, (ii) BnOH, BF3?OEt2, CH3NO2, 80 uC, 7 h, (iii) NaOMe, MeOH,
0 uC, 3 h, 68% from D-ManNAc; (b) (i) 2,2-dimethoxypropane, PTSA,
DMF, rt, 1 h, (ii) Ac2O, pyridine, rt, 24 h, 84% from 2; (c) 80% AcOH,
80 C, quant.; (d) RfCl 5, iPr2NEt, DMF, 45 uC, 54 h, 81%; (e) (i) NaOMe,
MeOH, 0 uC, 2 h, (ii) 20% Pd(OH)2/C, H2, MeOH, rt, 24 h, 94% from 6.
4 (a) K. Ikeda, M. Sato and Y. Torisawa, Curr. Med. Chem., 2004, 3, 339;
(b) J. C. Wilson, R. J. Thomson, J. C. Dyason, P. Florio, K. J. Quelch,
S. Abo and M. von Itzstein, Tetrahedron: Asymmetry, 2000, 11, 53.
5 (a) I. T. Horvath and J. Rabai, Science, 1994, 266, 72; (b) D. P. Cuuran,
Angew. Chem., Int. Ed., 1998, 37, 1174; (c) K. Goto, T. Miura,
M. Mizuno, H. Takaki, N. Imai, Y. Murakami and T. Inazu, Synlett,
2004, 2221; (d) D. P. Curran, Pure Appl. Chem., 2000, 72, 1649.
6 (a) D. P. Curran and Z. Y. Luo, J. Am. Chem. Soc., 1999, 121, 9069; (b)
D. P. Curran, Synlett, 2001, 1488; (c) Z. Y. Luo, Q. S. Zhang,
Y. Oderaotoshi and D. P. Curran, Science, 2001, 291, 1766.
Table 1 Neu5Ac aldolase-catalyzed reaction using fluorous protect-
ing group
7 (a) M. Murakami, K. Ikeda and K. Achiwa, Carbohydr. Res., 1996, 280,
101; (b) K. Ikeda, F. Kimura, K. Sano, Y. Suzuki and K. Achiwa,
Carbohydr. Res., 1998, 312, 183.
8 Experimental data for 5: Anhydrous hydrogen chloride was passed
through a mixture of 2-(perfluorohexyl)ethanol (10.9 g, 30 mmol) and
paraformaldehyde powder (0.99 g, 33 mmol) at 20–25 uC for 2 h. The
reaction mixture was transferred into a separating funnel and the upper
layer was diluted with pentane. The organic layer was dried over
anhydrous MgSO4 and concentrated to give 10.9 g (86%) of crude 5 as a
colorless oil. Distillation of this oil gave pure 5 (45 mmHg, bp 83–85 uC).
1H NMR (CDCl3, 500 MHz): d 2.43–2.49 (m, 2H, ClCH2OCH2CH2),
3.96–4.00 (m, 2H, ClCH2OCH2CH2), 5.50 (m, 2H, ClCH2OCH2CH2).
13C NMR (CDCl3, 125 MHz): d 29.1 (t, JCF = 22.2 Hz), 60.4, 80.4,
106.7–116.5 (m, C6F13). 19F NMR (CDCl3, 470 MHz): d 2126.7,
2124.2, 2123.4, 2122.4, 2114.0, 281.4. Negative FABMS (TEA) m/z:
377 (M-Cl)+.
Entry
Condition
Yield (%)
1
2
Neu5Ac aldolase KpB (pH 7.5) MgCl2,
DTT, 37 uC, 7 d
Neu5Ac aldolase HFE-7200-KpB (pH 7.5)
62
71
(1 : 5) MgCl2, DTT, 37 uC, 7 d
9 J. L.-C. Lin, G. -J. Shen, Y. Ichikawa, J. F. Rutant, G. Zapata,
W. F. Vann and C. -H. Wong, J. Am. Chem. Soc., 1992, 114, 3901.
10 EtOC4F9 is a commercially available fluorocarbon solvent (3 M,
Tokyo), which is called Novec2 HFE-7200.
11 Experimental data of Neu5Ac aldolase catalyzed reaction: Neu5Ac
aldolase [10 unit] was added to a solution of 7 (60 mg, 0.10 mmol) and
sodium pyruvate (110 mg, 1.0 mmol) in 0.05 M KpB (pH 7.5) (2 ml)
and HFE-7200 (0.4 ml) in the presence of DTT (1.4 mg) and 0.1 M
MgCl2 (0.10 ml) at 37 uC. After 2 days, an additional amount of
aldolase (10 unit) and sodium pyruvate (110 mg, 1.20 mmol) was added.
The mixture was incubated for a further 5 days at 37 uC. The course of
the reaction was monitored by TLC. The whole solution was passed
through a column of Bio-Gel P-2 gel filtration chromatography using
water as eluant. Fractions containing the product were purified on a
column of FRPS chromatogaraphy eluted first with 80% MeOH2H2O
and then with MeOH to give 8 (50 mg, 71%), as amorphous after freeze
drying. Positive FABMS (NBA) m/z: 708 (M + H)+, 730 (M + Na)+.
12 Selected data for 10: 1H NMR (CDCl3, 500 MHz): d 1.90 (s, 3H,
NHAc), 2.04, 2.06, 2.09 (s, each 3H, OAc), 2.3422.48 (m, 2H,
OCH2OCH2CH2), 3.63 (dd, 1H, J9a,9b = 11.5, J9a,8 = 6.9 Hz H-9a), 3.77
Scheme 3 Reagents and conditions: (a) TMSCHN2, CH2Cl2, rt, 24 h,
quant. from 8; (b) (i) AcCl, rt, 24 h; (ii) pyridine, rt, 1 h, 87% from 9; (c) (i)
NaOMe, MeOH, 0 uC, 2 h; (ii) TMSBr, CH2Cl2, 0 uC, 12 h, 67% from 10.
(s, 3H, OMe), 3.80–3.84 (m, 2H, OCH2OCH2CH2), 4.07 (dd, 1H, J9b,8
=
3.5 Hz H-9b), 4.68, 4.69 (d, each 1H, Jgem = 16.6 Hz, OCH2OCH2CH2),
5.98 (d, 1H, J3,4 = 3.5 Hz, H-3). 13C NMR (CDCl3, 125 MHz): d 20.7,
20.8, 20.9, 23.2, 31.4 (t, JCF = 21.6 Hz), 46.5, 52.6, 60.0, 65.8, 67.8, 68.1,
71.9, 95.7, 107.9, 116.1–118.4 (m, C6F13), 145.0, 161.7, 170.1, 170.3,
170.5, 170.8. 19F NMR (CDCl3, 470 MHz): d 2126.7, 2124.2, 2123.4,
2122.4, 2114.1, 281.3. Positive FABMS (NBA) m/z: 830 (M + Na)+.
13 S. Hanessian, D. Delorme and Y. Dufresne, Tetrahedron Lett., 1984, 25,
2515.
separated over FRPS chromatography. Finally, after the stepwise
removal of acetyl groups and methyl ester group, deprotection of
the fluorous acetal group with trimethylsilyl bromide (TMSBr)13
under mildly acidic conditions gave 1.14
In conclusion, we have demonstrated the first chemoenzymatic
synthesis of sialic acid derivatives by using the FSPE technique and
14 The spectral data of 1 were consistent with an authentic sample.
3094 | Chem. Commun., 2006, 3093–3094
This journal is ß The Royal Society of Chemistry 2006